UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.277

Sortiert nach

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3188-3194

1999

Volltextzugriff (PDF)

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

Annals of oncology, 2017-06, Vol.28 (6), p.1316-1324

2017

Volltextzugriff (PDF)

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition

Clinical cancer research, 1996-04, Vol.2 (4), p.659-668

1996

Volltextzugriff (PDF)

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer

Thorax, 2009-01, Vol.64 (1), p.75-80

2009

Volltextzugriff (PDF)

Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin

Annals of oncology, 2001-02, Vol.12 (2), p.245-248

2001

Volltextzugriff (PDF)

Hepatocellular carcinoma

Annals of oncology, 2001-02, Vol.12 (2), p.161-172

2001

Volltextzugriff (PDF)

Preoperative Mitomycin, Ifosfamide, and Cisplatin Followed by Esophagectomy in Squamous Cell Carcinoma of the Esophagus: Pathologic Complete Response Induced by Chemotherapy Leads to Long-Term Survival

Journal of clinical oncology, 2003-11, Vol.21 (21), p.4009-4015

2003

Volltextzugriff (PDF)

Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? a study based on West Midlands cancer registration data

British journal of cancer, 2006-10, Vol.95 (7), p.835-840

2006

Volltextzugriff (PDF)

Anti-proliferative activity and mechanism of action of titanocene dichloride

British journal of cancer, 1998-06, Vol.77 (12), p.2088-2097

1998

Volltextzugriff (PDF)

Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2761-2769

1998

Volltextzugriff (PDF)

Clinical trials of p-glycoprotein reversal in solid tumours

European journal of cancer (1990), 1996-06, Vol.32 (6), p.1070-1081

1996

Volltextzugriff (PDF)

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

Journal of controlled release, 1999-02, Vol.57 (3), p.281-290

1999

Volltextzugriff (PDF)

The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells

British Journal of Cancer, 1999-11, Vol.81 (6), p.942-951

1999

Volltextzugriff (PDF)

Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?

Postgraduate medical journal, 2005-11, Vol.81 (961), p.e17-e17

2005

Volltextzugriff (PDF)

Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells

British journal of cancer, 1996-05, Vol.73 (9), p.1063-1068

1996

Volltextzugriff (PDF)

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

British Journal of Cancer, 1999-11, Vol.81 (5), p.783-789

1999

Volltextzugriff (PDF)

Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy

The New England journal of medicine, 1998-06, Vol.338 (25), p.1785-1792

1998

Volltextzugriff (PDF)

Testing the role of P-glycoprotein expression in clinical trials: applying pharmacological principles and best methods for detection together with good clinical trials methodology

International journal of clinical pharmacology and therapeutics, 1998-01, Vol.36 (1), p.29

Ferry, D R

1998

Volltextzugriff (PDF)

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints

Annals of oncology, 2000-09, Vol.11 (9), p.1165-1170

2000

Volltextzugriff (PDF)

P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site

Biochemical and biophysical research communications, 1992-10, Vol.188 (1), p.440-445

1992

Volltextzugriff (PDF)

A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma

International journal of oncology, 1998-06, Vol.12 (6), p.1217

1998

Volltextzugriff (PDF)

Allosteric regulation of [ 3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine

Biochemical pharmacology, 1995-06, Vol.49 (12), p.1851-1861

1995

Volltextzugriff (PDF)

Effect of quercetin on the genotoxic potential of cisplatin

International journal of cancer, 1996-05, Vol.66 (3), p.404-408

1996

Volltextzugriff (PDF)

The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interface

Biochimica et biophysica acta, 1997-09, Vol.1328 (2), p.109-124

1997

Volltextzugriff (PDF)

Dexniguldipine-HCl is a potent allosteric inhibitor of [ 3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells

European journal of pharmacology, 1994-12, Vol.288 (1), p.105-114

1994

Volltextzugriff (PDF)

1 – 25 von 1.277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.075)
Mit Volltextzugriff
(1.145)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.188)
Japanisch
(159)
Französisch
(85)
Deutsch
(10)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(803)
Life Sciences & Biomedicine
(419)
Humans
(359)
Physical Sciences
(341)
Physics
(281)
Male
(229)
Female
(223)
Biological And Medical Sciences
(174)
Technology
(167)
Middle Aged
(149)
Medical Sciences
(148)
Adult
(137)
Physics, Condensed Matter
(132)
Exact Sciences And Technology
(129)
Physics, Applied
(126)
Engineering
(108)
Aged
(101)
Engineering, Electrical & Electronic
(98)
Animals
(93)
Materials Science
(74)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer

Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin

Hepatocellular carcinoma

Preoperative Mitomycin, Ifosfamide, and Cisplatin Followed by Esophagectomy in Squamous Cell Carcinoma of the Esophagus: Pathologic Complete Response Induced by Chemotherapy Leads to Long-Term Survival

Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? a study based on West Midlands cancer registration data

Anti-proliferative activity and mechanism of action of titanocene dichloride

Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer

Clinical trials of p-glycoprotein reversal in solid tumours

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells

Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?

Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy

Testing the role of P-glycoprotein expression in clinical trials: applying pharmacological principles and best methods for detection together with good clinical trials methodology

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints

P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site

A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma

Allosteric regulation of [ 3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine

Effect of quercetin on the genotoxic potential of cisplatin

The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interface

Dexniguldipine-HCl is a potent allosteric inhibitor of [ 3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells

Suchergebnisse filtern